the researchers will use their new funding to strengthen a vaccine they have made from a dna fragment taken from the hiv genome . the fragment encodes something that is highly prized in hiv / aids vaccine research . called the mper , it is a region of the hiv envelope that retains mutations at a very low level compared to the rest of the virus genome , which continually mutates . '